3rd Quarter - Report

CAPITOL HEALTH GROUP, LLC for AMERISOURCEBERGEN CORPORATION

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.905 - To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. S.733 - A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. H.R.674 - To amend the Internal Revenue Code of 1986 to repeal the imposition of 3 percent withholding on certain payments made to vendors by government entities. S.89 - Withholding Tax Relief Act of 2011 S.164 - Withholding Tax Relief Act of 2011 H.R.1483 - Drug Safety Enhancement Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 S.1584 - Drug Safety and Accountability Act of 2011 H.R.2245 - Preserving Access to Life-Saving Medications Act of 2011 S.296 - Preserving Access to Life-Saving Medications Act

LobbyistCovered position, as disclosed
CHELSEA ARNONE Temporary Employee, Congressman Fred Upton
MICHAEL BROMBERG —
SHAWN COUGHLIN —
JENNIFER HIGGINS —
STEVEN JENNING —

Contacted: Medicare Payment Advisory Commission (MedPAC); SENATE; Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); Agency for Healthcare Research & Quality (AHRQ); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 164 (112th), H.R. 2245 (112th), H.R. 905 (112th), S. 1584 (112th), S. 89 (112th), H.R. 3026 (112th), S. 296 (112th), H.R. 1483 (112th), S. 733 (112th), H.R. 674 (112th)

Medicare/Medicaid MMM

H.R.905 - To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. S.733 - A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. H.R.674 - To amend the Internal Revenue Code of 1986 to repeal the imposition of 3 percent withholding on certain payments made to vendors by government entities. S.89 - Withholding Tax Relief Act of 2011 S.164 - Withholding Tax Relief Act of 2011 H.R.1483 - Drug Safety Enhancement Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 S.1584 - Drug Safety and Accountability Act of 2011 H.R.2245 - Preserving Access to Life-Saving Medications Act of 2011 S.296 - Preserving Access to Life-Saving Medications Act

LobbyistCovered position, as disclosed
CHELSEA ARNONE Temporary Employee, Congressman Fred Upton
MICHAEL BROMBERG —
SHAWN COUGHLIN —
JENNIFER HIGGINS —
STEVEN JENNING —

Contacted: SENATE; Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); Agency for Healthcare Research & Quality (AHRQ); Office of Management & Budget (OMB); Executive Office of the President (EOP); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 296 (112th), H.R. 905 (112th), S. 164 (112th), S. 1584 (112th), S. 733 (112th), H.R. 674 (112th), H.R. 3026 (112th), H.R. 1483 (112th), S. 89 (112th), H.R. 2245 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.